Tuesday, January 04, 2005
Ingen Tecnologies Issues Shareholder Update
�
For Immediate Release:
Calimesa, CA- January 04, 2005: Ingen Technologies’ (OTC:IGTN) president and CEO, Scott Sand today issued the following shareholder update:
Dear Valued Shareholders:
With a new year upon us, now is an excellent time to update our valued shareholders on Ingen Technologies’ progress to-date as well as future growth opportunities.
In 2004, Ingen accomplished a number of significant milestones with our industry-first product lines and proprietary SecureBalance� program.
Now in the final stages of development, BAFI�, OxyAlert� and GasAlert� should produce dramatic sales and are actively pursuing sales and marketing agreements with distribution channels worldwide. Several large healthcare and medical supply firms have indicated substantial interest, which we believe will bear fruit in the first quarter of 2005.
We are confident that initial rounds of financing and prospective sources will be sufficient to ensure the market success of these industry-first products. Current investors, including an Asian investment group, have indicated long-term interest in the Company, and we are actively pursuing acquisition candidates that provide complementary products and services to further develop our lines.
Roll-out of SecureBalance� in 2004 has been successful in its respective medical and healthcare fields, thus exceeding last year revenues of $1M. The industry-leading program has tremendous exposure and has benefited significantly from national ventures with major medical industry professionals including: Southeastern Neuroscience Institute, Preferred Provider Care, Total Healthcare Compliance, Stanford Trading Center and Medicore, Inc, to name a few. We are confident that the necessary drivers are now in place to provide substantial revenue streams from the SecureBalance� program over the next several months.
Ingen has grown substantially in 2004, and we look forward to benefiting from that in 2005. In the coming months, we expect to provide enhanced shareholder value from a number of potential contracts that allow for dramatic growth in revenue from the BAFI�, OxyAlert� and GasAlert� product lines. As sales and marketing campaigns for SecureBalance� continue through 2005, and we pursue complementary acquisition candidates, we intend to secure a number of additional revenue streams for the Company.
Look for the success of our Pure Produce� program in 2005. Pure Produce� is a hydroponic/Aeroponic farming technology that will provide increased soilless crop production with a 95% decrease in water consumption and no toxic pesticides. “I am scheduled to meet with serious investors in Singapore next month. The first 20,000 sq.ft. facility is being built in Southern California as a test beta site. This is the newest technology for feeding growing populations and starving countries worldwide. We can supply produce, year round, that is of the highest quality in large quantities.”, said Scott Sand, CEO & Chairman of Ingen Technologies.
Thank you for your continued support of Ingen Technologies -- we look forward to a healthy and prosperous new year with our valued shareholders.
Scott Sand, President and CEO
Ingen Technologies
About Ingen Technologies
Ingen Technologies, Inc. is a public company trading on OTC: IGTN. In business since 1999, Ingen Technologies is a growth-oriented technology company that offers a diverse and progressive service and product line.
The Company’s flagship products are its BAFI�, GasAlert� and OxyAlert� products, the world’s first wireless digital low gas warning system for pressurized gas cylinders. The BAFI� received a US Patent on October 24th, 2000, Patent No. 6,137,417. BAFI�, now in its second generation, is an accurate and cost-effective, real-time pressurized gas warning system that will alert users when gas levels are approaching empty.
The BAFI� line has multiple applications, inclusive but not limited to, the Medical Industry, Home Consumer, Residential Development Industry, Safety & Protection (fire and police), Aircraft Industry, and the Recreational Vehicle Industry. BAFI� meets or exceeds regulatory compliance of this type of product and is completed and in production.
The successful Secure Balance� program is equipment, training and an educational support system available to physicians throughout the United States. During the initial twelve months, the Secure Balance� system generated approximately $1 million in revenues for Ingen and is now being aggressively marketed throughout the United States. More recently, the company’s sales have increased in proportion to the expansion of the Company’s marketing network. Its marketing strength is based upon superior products and an experienced, professional team.
The Secure Balance� program offers the most sophisticated clinical products for vestibular function testing and balance therapy compared to any of their competitors. With more than two million people visiting their doctor each year complaining of dizziness and vertigo; Secure Balance � can substantially help patients regain their balance and decrease the number of fall related injuries. The elderly population is expected to double over the next decade and comprise the majority of balance disorder patients.
�
For more information, visit: www.otcfn.com/crtz and www.ingen-tech.com
Investor Relations Contact: �Scott R. Sand, C.E.O & Chairman
�����Ingen Technologies, Inc.
�����285 E. County Line Road
�����Calimesa, CA 92320
�����800-259-9622
�����951-675-3266
�����800-777-1186 FAX
�����[email protected]
�����Rick McCaffrey, Investor Relations
�����OTC Financial Network
�����781-444-6100 x625
�����781-444-6101 FAX
�����[email protected]
Safe Harbor for Forward-Looking Statements:� This news release includes forward-looking statements that are made pursuant to “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.
Download this article in PDF format: IGTNshareletter010305d2.pdf
